Shin Nippon Biomedical Laboratories2395 
$8.251.12%24h
1.12%24h
Global rank13865
Market cap$343.50M
Change 7d-2.49%
YTD Performance-30.16%
SP500 benchmarkUnderperform
P/E0.06
P/S1.95
Revenue$176.34M
Earnings$42.53M
Dividend yield-
Main Sector
Healthcare
Shin Nippon Biomedical Laboratories (2395) Total Liabilities
2395 Total Liabilities in 2022: $217.05M
According to Shin Nippon Biomedical Laboratories latest financial reports the total liabilities of 2395 is $217.05M, an increase of 57.65% to 2022. At the end of 2022 company had $137.68M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Shin Nippon Biomedical Laboratories is responsible for during its operational activities.
Shin Nippon Biomedical Laboratories (2395) Total Liabilities History from 2023 to 2022
-
Value:-
2395 Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $217.05M | 57.65% |
| 2022 | $137.68M | -7.31% |
| 2021 | $148.53M | -6.57% |
| 2020 | $158.98M | 24.92% |
| 2019 | $127.27M | - |
View the Top Total Liabilies Stocks
